dibenzepin
Sign in to saveAlso known as NOV482
Dibenzepin, sold under the brand name Noveril among others, is a tricyclic antidepressant (TCA) used widely throughout Europe for the treatment of depression. It has similar efficacy and effects relative to other TCAs like imipramine but with fewer side effects.
Key facts
- Drug.legal_status
- Rx-only
- Drug.width
- 190
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 447436237
- Drug.IUPAC_name
- 10-(2-(dimethylamino)ethyl)-5-methyl-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one
- Drug.image
- Dibenzepin Structural Formula V1.svg
- Drug.image_class
- skin-invert-image
- Drug.alt
- Skeletal formula of dibenzepin
- Drug.image2
- Dibenzepin 3D spacefill.png
- Drug.image_class2
- bg-transparent
- Drug.alt2
- Space-filling model of the dibenzepin molecule
- Drug.tradename
- Noveril, Anslopax, Deprex, Ecatril, Neodit, Victoril
- Drug.legal_BR
- C1
- Drug.routes_of_administration
- Oral
- Drug.bioavailability
- 25%
- Drug.protein_bound
- 80%
- Drug.metabolism
- Hepatic
- Drug.elimination_half life
- 5 hours
via Wikipedia infobox
~3 min read
Encyclopedic overview
10 sectionsContents
- Medical uses
- Overdose
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- History
- Society and culture
- Brand names
- References
- External links
Dibenzepin, sold under the brand name Noveril among others, is a tricyclic antidepressant (TCA) used widely throughout Europe for the treatment of depression. It has similar efficacy and effects relative to other TCAs like imipramine but with fewer side effects.
==Medical uses== Dibenzepin is used mainly in the treatment of major depressive disorder.
Excerpted from Wikipedia’s “dibenzepin” article, available under the CC BY-SA 4.0 licence.